These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7713601)

  • 21. [Technical problems in platelet-concentrate preparation and their clinical significance].
    Stampe D
    Infusionsther Klin Ernahr; 1977 Jun; 4(3):152-6. PubMed ID: 561028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scotblood 2012: transfusion/transplant medicine in the 2nd decade of the 21st century.
    Colligan D; McGowan N; Seghatchian J
    Transfus Apher Sci; 2013 Jun; 48(3):415-20. PubMed ID: 23643474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in the clinical use of blood derivatives.
    Govaerts A
    Acta Anaesthesiol Belg; 1984; 35 Suppl():5-8. PubMed ID: 6516758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of an electromechanical infusion pump for transfusion of platelet concentrates.
    Snyder EL; Ferri PM; Smith EO; Ezekowitz MD
    Transfusion; 1984; 24(6):524-7. PubMed ID: 6506186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte-reduced blood components: patient benefits and practical applications.
    Higgins VL
    Oncol Nurs Forum; 1996 May; 23(4):659-67. PubMed ID: 8735324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of IL-8 and TNF-alpha in platelet concentrates during storage.
    Shaiegan M; Pourfatollah AA; Namiri M; Babaee G
    Arch Iran Med; 2006 Jan; 9(1):61-4. PubMed ID: 16649381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates.
    Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG
    Transfusion; 1977; 17(6):657-61. PubMed ID: 595123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer simulation of transfusion with different blood product ratios in modern massive transfusion protocols.
    Ho AM; Ho AK; Mizubuti GB
    Med Hypotheses; 2019 Apr; 125():10-15. PubMed ID: 30902133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory factors underlying refractoriness to platelet transfusions.
    Friedberg RC
    J Clin Apher; 1996; 11(3):143-8. PubMed ID: 8915819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quick and efficient way to pool platelets.
    Gorgone BC; Coliano FR; Tuttle SA; Ervin TJ
    Transfusion; 1983; 23(1):70-1. PubMed ID: 6829063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombocyte crossmatching: clinical experience with the Capture P-test].
    Böck M; Heim MU; Schleich I; Weindler R; Mepel W
    Beitr Infusionsther; 1990; 26():150-2. PubMed ID: 1703817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
    Hux BD; Martin LG
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB; Duke JC; Romine M
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swedish transfusion medicine in a ten-year perspective--a brief review.
    Högman CF
    Ups J Med Sci; 1988; 93(2):189-92. PubMed ID: 3144789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet transfusion. Current techniques, remaining problems, and future prospects.
    Herman JH; Kamel HT
    Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.